Evidence map›Paper›PMID 28754961›Full record

ArticleScientific reports2017

The Maintenance of Telomere Length in CD28+ T Cells During T Lymphocyte Stimulation.

Ejun Elijah Huang, Enzo Tedone, Ryan O'Hara, Crystal Cornelius, Tsung-Po Lai, Andrew Ludlow, Woodring E Wright, Jerry W Shay

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Reliable Hallmarks and Biomarkers of Senescent Lymphocytes.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Immunosenescence, aging and successful aging.Frontiers in immunology · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ejun Elijah HuangDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Enzo TedoneDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Ryan O'HaraDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Crystal CorneliusDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Tsung-Po LaiDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Andrew LudlowDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.
Woodring E WrightDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA.ORCID 0000-0001-6838-6665
Jerry W ShayDepartment of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA. Jerry.Shay@UTSouthwestern.edu.

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Cell Biology Research Improvements and RenovationsC06RR030414 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI FITZ, JOHN GREGORY · 2010 to 2010
$15.0M
GENE EXPRESSION IN AGING AND DEVELOPMENTR01AG001228 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI SHAY, JERRY WILLIAM · 1985 to 2018
$7.6M
Manipulating hTERT splicing in lung cancer cells.R00CA197672 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUDLOW, ANDREW TODD · 2017 to 2019
$738k
Manipulating hTERT splicing in lung cancer cells.K99CA197672 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI LUDLOW, ANDREW TODD · 2016 to 2017
$289k
NCI NIH HHS K99 CA197672NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA070907NCI NIH HHS R00 CA197672NCRR NIH HHS C06 RR030414NIA NIH HHS R01 AG001228
6 · The paper itself

Abstract

Telomerase activity is not readily detected in resting human T lymphocytes, however upon antigen presentation, telomerase is transiently upregulated. Presently, it is not known if telomerase activation is necessary for the proliferation of T cells or for the maintenance of telomere lengths. In this study, we found that telomerase activation is not required for the short- term proliferation of T cells and that telomeres progressively shorten in a heterogeneous population of T cells, even if telomerase is detected. By measuring telomerase activity at the single-cell level using quantitative ddPCR techniques (ddTRAP) and by monitoring changes in the shortest telomeres with more sensitive telomere length measurement assays, we show that only a subset of CD28+ T-cells have robust telomerase activity upon stimulation and are capable of maintaining their telomere lengths during induced proliferation. The study of this T-cell subset may lead to a better understanding on how telomerase is regulated and functions in immune cells.

Indexed as

Lymphocyte ActivationTelomere HomeostasisAdultCD28 AntigensCells, CulturedHumansTelomeraseT-LymphocytesCD28 AntigensTelomerase

Identifiers

PMID28754961
PMCPMC5533788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.